 | This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Paul G. Allen Frontiers Group" – news · newspapers · books · scholar · JSTOR (March 2016) (Learn how and when to remove this message) |
The Paul G. Allen Frontiers Group is a Seattle-based bioscience research initiative started in 2016 and funded with an initial investment of $100 million. It is a division of the Allen Institute. Its vision is to identify areas in bioscience that are ripe for a major breakthrough, and then fund specific investigators to pursue advances.
In 2021, the Allen Frontiers Group joined the Open Research Funders Group (ORFG).
Allen Distinguished Investigators
The Distinguished Investigator program "awards grants of $1.5 million of three years in support of early-stage research in biology and medicine that would not otherwise be supported by traditional funding sources."
External links
References
- Cha, Ariana Eunjung (2021-10-26). "Philanthropist Paul Allen announces $100 million gift to expand 'frontiers of bioscience'". Washington Post. ISSN 0190-8286. Retrieved 2023-11-07.
- Savchuk, Katia. "Billionaire Paul Allen Pledges $100 Million To Fund Cutting-Edge Life Sciences Research". Forbes. Retrieved 2023-11-07.
- "Microsoft pioneer invests big, again, in bioscience". Sciencemag.org. Retrieved March 24, 2016.
- "Allen Frontiers Group Joins ORFG". Open Research Funders Group. 2021-09-29. Retrieved 2023-11-07.
- "Frontiers Group announces 2021 Allen Distinguished Investigators". Philanthropynewsdigest.org.
 | This article about an organization in the United States is a stub. You can help Misplaced Pages by expanding it. |
 | This article about a biology organization is a stub. You can help Misplaced Pages by expanding it. |